Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Mar 11, 2014 5:12pm
148 Views
Post# 22310057

RE:RE:RE:perspectives

RE:RE:RE:perspectivesHi narmac.

I don't think it's a not for profit attitude at all. I believe these are highly motivated, very bright people. I just think it's a box or paradigm they may be stuck in. Eastern's commitment seems to be there for sure. I'm sure they are not there for purely philanthropic reasons. They should have a real sense of urgency in terms of bringing the best resources to the table to keep this moving. Keep in mind, these are only my persectives. I have not studied them.

As they've achieved significant progress over the last 14 years the corporate culture develops. The culture of the early days needs to evolve precisely because of their achievements.

Also, when you(RVX) have figured out how to pay yourself and employees a good buck and feel confident about future funding (which does reflect confidence in their scientific findings) you may lose some edge on the intensity of your business efforts...but I seriously doubt this for Resverlogix.

Anyway, just some thoughts.
Toinv.
Bullboard Posts